Fragmin

Fragmin (Dalteparin Sodium) is a low-molecular-weight heparin used for anticoagulation. It is commonly administered for blood clot prevention and treatment, including during haemodialysis.

Fragmin is primarily used to prevent and treat blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism. It is also used during haemodialysis to prevent blood clotting in the dialysis circuit. Fragmin may be prescribed for other conditions where anticoagulation is necessary, as determined by a healthcare provider.

Common effects of Fragmin may include bruising, bleeding, and pain or irritation at the injection site. Some users may experience allergic reactions, though these are less common. Always consult a healthcare provider if you experience severe or persistent side effects.

Fragmin should be handled with care to avoid accidental injury. It is important to follow the administration instructions provided by your healthcare provider. Store Fragmin as directed, typically at room temperature, and keep it out of reach of children. Do not use Fragmin if you are allergic to dalteparin sodium or any of its components.

Fragmin may interact with other medications that affect blood clotting, such as warfarin, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs). Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, certain medical conditions, such as kidney or liver disease, may affect the use of Fragmin.